Click for best price
Dermatological OTC Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Dermatological OTC Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatological OTC Drugs. This report contains market size and forecasts of Dermatological OTC Drugs in global, including the following market information:
Global Dermatological OTC Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Dermatological OTC Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Acne Medications Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Dermatological OTC Drugs include Perrigo Company plc, Bausch Health Companies Inc., Dr. Reddy's Laboratories, Johnson and Johnson, Bayer AG, GlaxoSmithKline plc., Viatris Inc, LEO Pharma A/S and Acella Pharmaceuticals, LLC, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dermatological OTC Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dermatological OTC Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Dermatological OTC Drugs Market Segment Percentages, by Type, 2022 (%)
Acne Medications
Dermatitis Drugs
Fungal Infection Drugs
Global Dermatological OTC Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Dermatological OTC Drugs Market Segment Percentages, by Application, 2022 (%)
Online Distribution
Offline Distribution
Global Dermatological OTC Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Dermatological OTC Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dermatological OTC Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Dermatological OTC Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Perrigo Company plc
Bausch Health Companies Inc.
Dr. Reddy's Laboratories
Johnson and Johnson
Bayer AG
GlaxoSmithKline plc.
Viatris Inc
LEO Pharma A/S
Acella Pharmaceuticals, LLC
Teva Pharmaceutical Industries Ltd.
Galderma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dermatological OTC Drugs, market overview.
Chapter 2: Global Dermatological OTC Drugs market size in revenue.
Chapter 3: Detailed analysis of Dermatological OTC Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dermatological OTC Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Dermatological OTC Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Dermatological OTC Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dermatological OTC Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dermatological OTC Drugs Overall Market Size
2.1 Global Dermatological OTC Drugs Market Size: 2022 VS 2029
2.2 Global Dermatological OTC Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Dermatological OTC Drugs Players in Global Market
3.2 Top Global Dermatological OTC Drugs Companies Ranked by Revenue
3.3 Global Dermatological OTC Drugs Revenue by Companies
3.4 Top 3 and Top 5 Dermatological OTC Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Dermatological OTC Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dermatological OTC Drugs Players in Global Market
3.6.1 List of Global Tier 1 Dermatological OTC Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Dermatological OTC Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Dermatological OTC Drugs Market Size Markets, 2022 & 2029
4.1.2 Acne Medications
4.1.3 Dermatitis Drugs
4.1.4 Fungal Infection Drugs
4.2 By Type - Global Dermatological OTC Drugs Revenue & Forecasts
4.2.1 By Type - Global Dermatological OTC Drugs Revenue, 2018-2023
4.2.2 By Type - Global Dermatological OTC Drugs Revenue, 2024-2029
4.2.3 By Type - Global Dermatological OTC Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dermatological OTC Drugs Market Size, 2022 & 2029
5.1.2 Online Distribution
5.1.3 Offline Distribution
5.2 By Application - Global Dermatological OTC Drugs Revenue & Forecasts
5.2.1 By Application - Global Dermatological OTC Drugs Revenue, 2018-2023
5.2.2 By Application - Global Dermatological OTC Drugs Revenue, 2024-2029
5.2.3 By Application - Global Dermatological OTC Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Dermatological OTC Drugs Market Size, 2022 & 2029
6.2 By Region - Global Dermatological OTC Drugs Revenue & Forecasts
6.2.1 By Region - Global Dermatological OTC Drugs Revenue, 2018-2023
6.2.2 By Region - Global Dermatological OTC Drugs Revenue, 2024-2029
6.2.3 By Region - Global Dermatological OTC Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Dermatological OTC Drugs Revenue, 2018-2029
6.3.2 US Dermatological OTC Drugs Market Size, 2018-2029
6.3.3 Canada Dermatological OTC Drugs Market Size, 2018-2029
6.3.4 Mexico Dermatological OTC Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Dermatological OTC Drugs Revenue, 2018-2029
6.4.2 Germany Dermatological OTC Drugs Market Size, 2018-2029
6.4.3 France Dermatological OTC Drugs Market Size, 2018-2029
6.4.4 U.K. Dermatological OTC Drugs Market Size, 2018-2029
6.4.5 Italy Dermatological OTC Drugs Market Size, 2018-2029
6.4.6 Russia Dermatological OTC Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Dermatological OTC Drugs Market Size, 2018-2029
6.4.8 Benelux Dermatological OTC Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Dermatological OTC Drugs Revenue, 2018-2029
6.5.2 China Dermatological OTC Drugs Market Size, 2018-2029
6.5.3 Japan Dermatological OTC Drugs Market Size, 2018-2029
6.5.4 South Korea Dermatological OTC Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Dermatological OTC Drugs Market Size, 2018-2029
6.5.6 India Dermatological OTC Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Dermatological OTC Drugs Revenue, 2018-2029
6.6.2 Brazil Dermatological OTC Drugs Market Size, 2018-2029
6.6.3 Argentina Dermatological OTC Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Dermatological OTC Drugs Revenue, 2018-2029
6.7.2 Turkey Dermatological OTC Drugs Market Size, 2018-2029
6.7.3 Israel Dermatological OTC Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Dermatological OTC Drugs Market Size, 2018-2029
6.7.5 UAE Dermatological OTC Drugs Market Size, 2018-2029
7 Dermatological OTC Drugs Companies Profiles
7.1 Perrigo Company plc
7.1.1 Perrigo Company plc Company Summary
7.1.2 Perrigo Company plc Business Overview
7.1.3 Perrigo Company plc Dermatological OTC Drugs Major Product Offerings
7.1.4 Perrigo Company plc Dermatological OTC Drugs Revenue in Global Market (2018-2023)
7.1.5 Perrigo Company plc Key News & Latest Developments
7.2 Bausch Health Companies Inc.
7.2.1 Bausch Health Companies Inc. Company Summary
7.2.2 Bausch Health Companies Inc. Business Overview
7.2.3 Bausch Health Companies Inc. Dermatological OTC Drugs Major Product Offerings
7.2.4 Bausch Health Companies Inc. Dermatological OTC Drugs Revenue in Global Market (2018-2023)
7.2.5 Bausch Health Companies Inc. Key News & Latest Developments
7.3 Dr. Reddy's Laboratories
7.3.1 Dr. Reddy's Laboratories Company Summary
7.3.2 Dr. Reddy's Laboratories Business Overview
7.3.3 Dr. Reddy's Laboratories Dermatological OTC Drugs Major Product Offerings
7.3.4 Dr. Reddy's Laboratories Dermatological OTC Drugs Revenue in Global Market (2018-2023)
7.3.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.4 Johnson and Johnson
7.4.1 Johnson and Johnson Company Summary
7.4.2 Johnson and Johnson Business Overview
7.4.3 Johnson and Johnson Dermatological OTC Drugs Major Product Offerings
7.4.4 Johnson and Johnson Dermatological OTC Drugs Revenue in Global Market (2018-2023)
7.4.5 Johnson and Johnson Key News & Latest Developments
7.5 Bayer AG
7.5.1 Bayer AG Company Summary
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Dermatological OTC Drugs Major Product Offerings
7.5.4 Bayer AG Dermatological OTC Drugs Revenue in Global Market (2018-2023)
7.5.5 Bayer AG Key News & Latest Developments
7.6 GlaxoSmithKline plc.
7.6.1 GlaxoSmithKline plc. Company Summary
7.6.2 GlaxoSmithKline plc. Business Overview
7.6.3 GlaxoSmithKline plc. Dermatological OTC Drugs Major Product Offerings
7.6.4 GlaxoSmithKline plc. Dermatological OTC Drugs Revenue in Global Market (2018-2023)
7.6.5 GlaxoSmithKline plc. Key News & Latest Developments
7.7 Viatris Inc
7.7.1 Viatris Inc Company Summary
7.7.2 Viatris Inc Business Overview
7.7.3 Viatris Inc Dermatological OTC Drugs Major Product Offerings
7.7.4 Viatris Inc Dermatological OTC Drugs Revenue in Global Market (2018-2023)
7.7.5 Viatris Inc Key News & Latest Developments
7.8 LEO Pharma A/S
7.8.1 LEO Pharma A/S Company Summary
7.8.2 LEO Pharma A/S Business Overview
7.8.3 LEO Pharma A/S Dermatological OTC Drugs Major Product Offerings
7.8.4 LEO Pharma A/S Dermatological OTC Drugs Revenue in Global Market (2018-2023)
7.8.5 LEO Pharma A/S Key News & Latest Developments
7.9 Acella Pharmaceuticals, LLC
7.9.1 Acella Pharmaceuticals, LLC Company Summary
7.9.2 Acella Pharmaceuticals, LLC Business Overview
7.9.3 Acella Pharmaceuticals, LLC Dermatological OTC Drugs Major Product Offerings
7.9.4 Acella Pharmaceuticals, LLC Dermatological OTC Drugs Revenue in Global Market (2018-2023)
7.9.5 Acella Pharmaceuticals, LLC Key News & Latest Developments
7.10 Teva Pharmaceutical Industries Ltd.
7.10.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.10.3 Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Revenue in Global Market (2018-2023)
7.10.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.11 Galderma
7.11.1 Galderma Company Summary
7.11.2 Galderma Business Overview
7.11.3 Galderma Dermatological OTC Drugs Major Product Offerings
7.11.4 Galderma Dermatological OTC Drugs Revenue in Global Market (2018-2023)
7.11.5 Galderma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Dermatological OTC Drugs Market Opportunities & Trends in Global Market
Table 2. Dermatological OTC Drugs Market Drivers in Global Market
Table 3. Dermatological OTC Drugs Market Restraints in Global Market
Table 4. Key Players of Dermatological OTC Drugs in Global Market
Table 5. Top Dermatological OTC Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Dermatological OTC Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Dermatological OTC Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Dermatological OTC Drugs Product Type
Table 9. List of Global Tier 1 Dermatological OTC Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dermatological OTC Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Dermatological OTC Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Dermatological OTC Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Dermatological OTC Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Dermatological OTC Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Dermatological OTC Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Dermatological OTC Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Dermatological OTC Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Dermatological OTC Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Dermatological OTC Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Dermatological OTC Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Dermatological OTC Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Dermatological OTC Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Dermatological OTC Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Dermatological OTC Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Perrigo Company plc Company Summary
Table 31. Perrigo Company plc Dermatological OTC Drugs Product Offerings
Table 32. Perrigo Company plc Dermatological OTC Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Perrigo Company plc Key News & Latest Developments
Table 34. Bausch Health Companies Inc. Company Summary
Table 35. Bausch Health Companies Inc. Dermatological OTC Drugs Product Offerings
Table 36. Bausch Health Companies Inc. Dermatological OTC Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Bausch Health Companies Inc. Key News & Latest Developments
Table 38. Dr. Reddy's Laboratories Company Summary
Table 39. Dr. Reddy's Laboratories Dermatological OTC Drugs Product Offerings
Table 40. Dr. Reddy's Laboratories Dermatological OTC Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Dr. Reddy's Laboratories Key News & Latest Developments
Table 42. Johnson and Johnson Company Summary
Table 43. Johnson and Johnson Dermatological OTC Drugs Product Offerings
Table 44. Johnson and Johnson Dermatological OTC Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Johnson and Johnson Key News & Latest Developments
Table 46. Bayer AG Company Summary
Table 47. Bayer AG Dermatological OTC Drugs Product Offerings
Table 48. Bayer AG Dermatological OTC Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Bayer AG Key News & Latest Developments
Table 50. GlaxoSmithKline plc. Company Summary
Table 51. GlaxoSmithKline plc. Dermatological OTC Drugs Product Offerings
Table 52. GlaxoSmithKline plc. Dermatological OTC Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. GlaxoSmithKline plc. Key News & Latest Developments
Table 54. Viatris Inc Company Summary
Table 55. Viatris Inc Dermatological OTC Drugs Product Offerings
Table 56. Viatris Inc Dermatological OTC Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Viatris Inc Key News & Latest Developments
Table 58. LEO Pharma A/S Company Summary
Table 59. LEO Pharma A/S Dermatological OTC Drugs Product Offerings
Table 60. LEO Pharma A/S Dermatological OTC Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. LEO Pharma A/S Key News & Latest Developments
Table 62. Acella Pharmaceuticals, LLC Company Summary
Table 63. Acella Pharmaceuticals, LLC Dermatological OTC Drugs Product Offerings
Table 64. Acella Pharmaceuticals, LLC Dermatological OTC Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Acella Pharmaceuticals, LLC Key News & Latest Developments
Table 66. Teva Pharmaceutical Industries Ltd. Company Summary
Table 67. Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Product Offerings
Table 68. Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 70. Galderma Company Summary
Table 71. Galderma Dermatological OTC Drugs Product Offerings
Table 72. Galderma Dermatological OTC Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Galderma Key News & Latest Developments
List of Figures
Figure 1. Dermatological OTC Drugs Segment by Type in 2022
Figure 2. Dermatological OTC Drugs Segment by Application in 2022
Figure 3. Global Dermatological OTC Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Dermatological OTC Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Dermatological OTC Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dermatological OTC Drugs Revenue in 2022
Figure 8. By Type - Global Dermatological OTC Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Dermatological OTC Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Dermatological OTC Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Dermatological OTC Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Dermatological OTC Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Dermatological OTC Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Dermatological OTC Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Dermatological OTC Drugs Revenue Market Share, 2018-2029
Figure 16. US Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Dermatological OTC Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Dermatological OTC Drugs Revenue Market Share, 2018-2029
Figure 28. China Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Dermatological OTC Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Dermatological OTC Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Dermatological OTC Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Perrigo Company plc Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bausch Health Companies Inc. Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Dr. Reddy's Laboratories Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson and Johnson Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bayer AG Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. GlaxoSmithKline plc. Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Viatris Inc Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. LEO Pharma A/S Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Acella Pharmaceuticals, LLC Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Galderma Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
